Physiological estrogen replacement therapy for puberty induction in girls: A clinical observational study

Hormone Research in Paediatrics

Volumn 81, Issue 4, 2014, Pages 239-244

  Ankarberg Lindgren, Carina ^a   Kriström, Berit ^b   Norjavaara, Ensio ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Estrogen deficiency; Growth; Hormone replacement therapy, transdermal; Ovarian failure; Turner syndrome

Indexed keywords

ESTRADIOL;

ADOLESCENT; ARTICLE; BODY WEIGHT; CHILD; CLINICAL STUDY; DELAYED PUBERTY; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; EXTRACTION; FEMALE; HUMAN; HYPOGONADISM; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; OUTPATIENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBERTY; RADIOIMMUNOASSAY; REFERENCE VALUE; RETROSPECTIVE STUDY; TRANSDERMAL PATCH; TURNER SYNDROME; ADULT; CLINICAL ARTICLE; OUTPATIENT DEPARTMENT; BLOOD; DRUG EFFECTS; TREATMENT OUTCOME;

ADOLESCENT; CHILD; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; HYPOGONADISM; PUBERTY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TURNER SYNDROME;

EID: 84901590704     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000356922     Document Type: Article

References (29)

1. Norjavaara E, Ankarberg C, Albertsson-Wikland K: Diurnal rhythm of 17 beta-estradiol secretion throughout pubertal development in healthy girls: evaluation by a sensitive radioimmunoassay. J Clin Endocrinol Metab 1996; 81: 4095-4102.
2. Ankarberg-Lindgren C, Norjavaara E: Estradiol in pediatric endocrinology. Am J Clin Pathol 2009; 132: 978-980.
3. Albin AK, Niklasson A, Westgren U, Norjavaara E: Estradiol and pubertal growth in girls. Horm Res Paediatr 2012; 78: 218-225.
4. Janner M, Fluck CE, Mullis PE: Impact of estrogen replacement throughout childhood on growth, pituitary-gonadal axis and bone in a 46,XX patient with CYP19A1 deficiency. Horm Res Paediatr 2012; 78: 261-268.
5. Ankarberg-Lindgren C, Elfving M, Wikland KA, Norjavaara E: Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls. J Clin Endocrinol Metab 2001; 86: 3039-3044.
6. Ankarberg-Lindgren C, Norjavaara E: A purification step prior to commercial sensitive immunoassay is necessary to achieve clinical usefulness when quantifying serum 17betaestradiol in prepubertal children. Eur J Endocrinol 2008; 158: 117-124.
7. Ankarberg-Lindgren C, Mahler TB, Norjavaara E: Biological reference intervals for serum estradiol and testosterone in children. Horm Res Paediatr 2013; 80(suppl 1):179.
8. Bondy CA, Turner Syndrome Study G: care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab 2007; 92: 10-25.
9. Davenport ML: Approach to the patient with Turner syndrome. J Clin Endocrinol Metab 2010; 95: 1487-1495.
10. Palmert MR, Dunkel L: Clinical practice. Delayed puberty. N Engl J Med 2012; 366: 443-453.
11. Reginster JY, Albert A, Deroisy R, Colette J, Vrijens B, Blacker C, Brion N, Caulin F, Mayolle C, Regnard A, Scholler R, Franchimont P: Plasma estradiol concentrations and pharmacokinetics following transdermal application of Menorest 50 or Systen (Evorel) 50. Maturitas 1997; 27: 179-186
12. erratum in Maturitas 1997; 28: 193-195.
13. Mora S, Weber G, Guarneri MP, Nizzoli G, Pasolini D, Chiumello G: Effect of estrogen replacement therapy on bone mineral content in girls with Turner syndrome. Obstet Gynecol 1992; 79: 747-751.
14. Carel JC, Elie C, Ecosse E, Tauber M, Leger J, Cabrol S, Nicolino M, Brauner R, Chaussain JL, Coste J: Self-esteem and social adjustment in young women with Turner syndrome-influence of pubertal management and sexuality: population-based cohort study. J Clin Endocrinol Metab 2006; 91: 2972-2979.
15. Ross JL, Roeltgen D, Feuillan P, Kushner H, Cutler GB Jr: Effects of estrogen on nonverbal processing speed and motor function in girls with Turner's syndrome. J Clin Endocrinol Metab 1998; 83: 3198-3204.
16. Norjavaara E, Albertsson Wikland K, Ankarberg-Lindgren C: A sensitive estradiol assay can predict the onset of puberty before thelarche. Horm Res 2005; 64(suppl 1):23.
17. Mauras N, Shulman D, Hsiang HY, Balagopal P, Welch S: Metabolic effects of oral versus transdermal estrogen in growth hormonetreated girls with Turner syndrome. J Clin Endocrinol Metab 2007; 92: 4154-4160.
18. Nabhan ZM, Dimeglio LA, Qi R, Perkins SM, Eugster EA: Conjugated oral versus transdermal estrogen replacement in girls with Turner syndrome: a pilot comparative study. J Clin Endocrinol Metab 2009; 94: 2009-2014.
19. Bannink EM, van Sassen C, van Buuren S, de Jong FH, Lequin M, Mulder PG, de Muinck Keizer-Schrama SM: Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels. Clin Endocrinol (Oxf) 2009; 70: 265-273.
20. Piippo S, Lenko H, Kainulainen P, Sipila I: Use of percutaneous estrogen gel for induction of puberty in girls with Turner syndrome. J Clin Endocrinol Metab 2004; 89: 3241-3247.
21. Scarabin PY, Oger E, Plu-Bureau G: Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk. Lancet 2003; 362: 428-432.
22. Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Levesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY, Estrogen Thromboembolism Risk Study G: Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the Esther Study. Circulation 2007; 115: 840-845.
23. L'Hermite M, Simoncini T, Fuller S, Genazzani AR: Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review. Maturitas 2008; 60: 185-201.
24. Opatrny L, Dell'Aniello S, Assouline S, Suissa S: Hormone replacement therapy use and variations in the risk of breast cancer. Br J Obstet Gynaecol 2008; 115: 169-175; discussion 175.
25. O'Sullivan AJ, Ho KK: Route-dependent endocrine and metabolic effects of estrogen replacement therapy. J Pediatr Endocrinol Metab 2000; 13(suppl 6):1457-1466.
26. Langrish JP, Mills NL, Bath LE, Warner P, Webb DJ, Kelnar CJ, Critchley HO, Newby DE, Wallace WH: Cardiovascular effects of physiological and standard sex steroid replacement regimens in premature ovarian failure. Hypertension 2009; 53: 805-811.
27. Alves ST, Gallichio CT, Guimaraes MM: Insulin resistance and body composition in Turner syndrome: effect of sequential change in the route of estrogen administration. Gynecol Endocrinol 2006; 22: 590-594.
28. Taboada M, Santen R, Lima J, Hossain J, Singh R, Klein KO, Mauras N: Pharmacokinetics and pharmacodynamics of oral and transdermal 17beta estradiol in girls with Turner syndrome. J Clin Endocrinol Metab 2011; 96: 3502-3510.
29. Harris HA, Bapat AR, Gonder DS, Frail DE: The ligand binding profiles of estrogen receptors alpha and beta are species dependent. Steroids 2002; 67: 379-384.